Intratumoral TLR-4 Agonist Injection Is Critical for Modulation of Tumor Microenvironment and Tumor Rejection
Figure 3
B16OVA tumor growth and OT-I T cell differentiation. (a) B16F10 (○) and B16OVA (▾) tumor measurements in OT-I injected mice. (b) Percentage of cells recovered from LN of OT-I transferred mice and injected with B16OVA (▾) and B16F10 (○) cells. (c) CD44 expression in OT-I cells recovered from LNs. Numbers on the upper right corner of histograms represent mean fluorescence () for each marker. Values of were considered statistically significant. Data representative of two different experiments, mice per group.
